RGNX 8-K 2026-06-29

REGENXBIO Inc. (RGNX) 8-K dated 2026-06-29 — accession 0001193125-26-286825. This URL is the filing, not the RGNX hub.

REGENXBIO Inc. (RGNX) is a biotechnology company listed on US.

REGENXBIO Inc. filed a 8-K on 2026-06-29. Accession 0001193125-26-286825.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.

Not investment advice. The RGNX SEC hub lists recent forms. The stock page is the research view.